Vaccine News and Research

Latest Vaccine News and Research

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Chatting on the phone with a "sleep coach" and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine.

24 May 2016

Novel strategy to predict antigenic evolution of circulating influenza viruses

During the 2014-15 flu season, the poor match between the virus used to make the world's vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.

24 May 2016

Heart failure patients who receive influenza vaccine less likely to develop dementia

Influenza vaccination is associated with a lower risk of dementia in patients with heart failure, according to a study in more than 20 000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr Ju-Chi Liu, director of the Division of Cardiovascular Medicine, Department of Medicine, Taipei Medical University - Shuang Ho Hospital, in New Taipei City, Taiwan.

24 May 2016

Cost-effectiveness tool can help guide decisions regarding proposed funds to combat Zika virus outbreak

A study published in PLOS Neglected Tropical Diseases presents a cost-effectiveness tool that can help guide decisions regarding resource allocation to fund interventions targeted at curtailing the ongoing Zika virus outbreak.

24 May 2016

Injectable IPV with bivalent oral vaccine safer than using oral vaccine alone

A groundbreaking study released today shows that a single injectable dose of inactivated polio vaccine (IPV) along with bivalent oral polio vaccine could protect up to 90 percent of children from polio and strengthen community protection against the disease.

23 May 2016

High-resolution image of Zika virus helicase may help develop antiviral drugs

A team led by researchers from Tianjin University has solved the structure of the Zika virus helicase, which is a key target for antiviral development. The research is published in Springer's journal Protein & Cell.

23 May 2016

New collaborative research center to investigate promising aspects of mucosal immunology

Immunology - and the idea that many diseases can best be addressed by boosting the body's own immune response - is one of the hottest areas in medical research and clinical treatment.

22 May 2016

Research provides pathway toward creation of first broad-spectrum antiviral drug

By studying the rare person -- about one in a million -- who can fight off viral infections more effectively than everyone else, investigators at the Icahn School of Medicine at Mount Sinai have developed a strategy to help the rest of us achieve this enhanced anti-viral state.

21 May 2016

NS5 viral protein could be promising vaccine target against Zika virus

A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health scientists and colleagues at Mount Sinai's Icahn School of Medicine.

20 May 2016

New skin test for TB infection proves safe, effective in clinical trials

A new skin test for tuberculosis infection has proven safe, easy to administer and accurate in two Phase III clinical trials, according to research presented at the ATS 2016 International Conference.

19 May 2016

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

19 May 2016

MSF responds to Lord O'Neill's recommendations on how to defeat drug resistance and superbugs

The O'Neill report confirms what MSF has long voiced. The pharmaceutical industry’s system for researching and developing medicines is not always delivering the drugs, vaccines and diagnostics needed. When they are developed, they are often unaffordable or not suitable for the people who need them most

19 May 2016

Experimental hepatitis C drug slows down development of Zika in mice

Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy.

17 May 2016

Rotavirus vaccine program reduces hospitalization rates by more than 70% in Ontario

Hospitalization for rotavirus infections decreased by > 70% following the introduction of a vaccine program in Ontario, Canada, according to a study published May 11, 2016 in the open-access journal PLOS ONE by Sarah Wilson from Public Health Ontario and the Institute for Clinical Evaluative Sciences, Canada, and colleagues.

13 May 2016

Potential vaccine that resembles sugar structures may help fight against gut bacterium C. difficile

A vaccine against one of the most dangerous hospital germs may soon be available. Scientists from the Max Planck Institute of Colloids and Interfaces in Potsdam and the Freie Universität Berlin have developed a substance that elicits an immune response against the gut bacterium Clostridium difficile.

13 May 2016

Drug-repositioning strategy could help combat Chikungunya virus

Since 2013, the mosquito-borne Chikungunya virus has spread rapidly through South America and the Caribbean, and is now threatening Southern Europe and the southern US.

13 May 2016

Tdap vaccine safe for mothers and infants

Tetanus-diphtheria-acellular pertussis (Tdap) vaccine is recommended for all pregnant women in the U.S. as the key medical intervention to protect newborn infants from pertussis (whooping cough).

12 May 2016

Mouse models of Zika virus infection in pregnancy provide basis to develop vaccines, treatments

Two mouse models of Zika virus infection in pregnancy have been developed by a team of researchers at Washington University School of Medicine in St. Louis. In them, the virus migrated from the pregnant mouse's bloodstream into the placenta, where it multiplied, then spread into the fetal circulation and infected the brains of the developing pups.

12 May 2016

Brazilian strain of Zika virus can cause severe birth defects

Researchers at University of California San Diego School of Medicine, with colleagues in Brazil and Senegal, have described the first "direct experimental proof" that the Brazilian strain of Zika virus can actually cause severe birth defects. The findings are published in the May 11 online issue of Nature.

12 May 2016

Researchers discover true Diels-Alder enzyme on the Pacific seabed

Scientists at the Universities of Bristol and Newcastle have uncovered the secret of the 'Mona Lisa of chemical reactions' - in a bacterium that lives at the bottom of the Pacific Ocean.

12 May 2016

Vaccine News and Research

Latest Vaccine News and Research

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Novel strategy to predict antigenic evolution of circulating influenza viruses

Heart failure patients who receive influenza vaccine less likely to develop dementia

Cost-effectiveness tool can help guide decisions regarding proposed funds to combat Zika virus outbreak

Injectable IPV with bivalent oral vaccine safer than using oral vaccine alone

High-resolution image of Zika virus helicase may help develop antiviral drugs

New collaborative research center to investigate promising aspects of mucosal immunology

Research provides pathway toward creation of first broad-spectrum antiviral drug

NS5 viral protein could be promising vaccine target against Zika virus

New skin test for TB infection proves safe, effective in clinical trials

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

MSF responds to Lord O'Neill's recommendations on how to defeat drug resistance and superbugs

Experimental hepatitis C drug slows down development of Zika in mice

Rotavirus vaccine program reduces hospitalization rates by more than 70% in Ontario

Potential vaccine that resembles sugar structures may help fight against gut bacterium C. difficile

Drug-repositioning strategy could help combat Chikungunya virus

Tdap vaccine safe for mothers and infants

Mouse models of Zika virus infection in pregnancy provide basis to develop vaccines, treatments

Brazilian strain of Zika virus can cause severe birth defects

Researchers discover true Diels-Alder enzyme on the Pacific seabed

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in